Author

M. Karbiener

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Approach:statistical model· 1 Research Focus:variant calling· 1

Frequent Co-Authors

T. R. Kreil· 3 shared J. Schwaiger· 2 shared M. R. Farcet· 2 shared A. Adonyi· 1 shared A.-D. Gorki· 1 shared C. Aberham· 1 shared D. Blaas· 1 shared D. Stoeva· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

T. R. Kreil

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivMay 24, 2022

Host-directed therapy with 2-Deoxy-D-glucose inhibits human rhinoviruses, endemic coronaviruses, and SARS-CoV-2

L. Wali, M. Karbiener, S. Chou…·A.-D. Gorki

This study shows 2-deoxy-D-glucose inhibits replication of rhinoviruses, endemic coronaviruses, and SARS-CoV-2 in epithelial cells by disrupting viral RNA synthesis and reducing viral load.

DOI 10.1016/j.jve.2022.100305

humanbulk RNA-seq

𝕏 PostBluesky

ImmunologybioRxivFeb 12, 2021

Rapidly Increasing SARS-CoV-2 Neutralization by Intravenous Immunoglobulins Produced from Plasma Collected During the 2020 Pandemic

M. R. Farcet, M. Karbiener, J. Schwaiger…·T. R. Kreil

The paper analyzes SARS-CoV-2 neutralizing antibody levels in intravenous immunoglobulins (IG) collected during the 2020 pandemic, showing increasing potency over time.

DOI 10.1093/infdis/jiab142

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivJul 30, 2020

No SARS-CoV-2 cross-neutralization by intravenous immunoglobulins produced from plasma collected before the 2020 pandemic

J. Schwaiger, M. Karbiener, C. Aberham…·T. R. Kreil

The paper tests 54 intravenous immunoglobulin preparations from pre-pandemic plasma and finds they neutralize seasonal coronavirus hCoV-229E but not SARS-CoV-2.

DOI 10.1093/infdis/jiaa593

humanproteomics

𝕏 PostBluesky